JP2021525738A5 - - Google Patents
Info
- Publication number
- JP2021525738A5 JP2021525738A5 JP2020566706A JP2020566706A JP2021525738A5 JP 2021525738 A5 JP2021525738 A5 JP 2021525738A5 JP 2020566706 A JP2020566706 A JP 2020566706A JP 2020566706 A JP2020566706 A JP 2020566706A JP 2021525738 A5 JP2021525738 A5 JP 2021525738A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazo
- pyrazine
- pyrido
- bromo
- methylpiperazine
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180062254 | 2018-05-31 | ||
| KR10-2018-0062254 | 2018-05-31 | ||
| PCT/KR2019/006553 WO2019231270A1 (en) | 2018-05-31 | 2019-05-31 | Heterocyclic derivatives and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525738A JP2021525738A (ja) | 2021-09-27 |
| JPWO2019231270A5 JPWO2019231270A5 (https=) | 2022-04-04 |
| JP2021525738A5 true JP2021525738A5 (https=) | 2022-04-04 |
Family
ID=68698381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566706A Withdrawn JP2021525738A (ja) | 2018-05-31 | 2019-05-31 | 複素環誘導体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210198259A1 (https=) |
| EP (1) | EP3807282A4 (https=) |
| JP (1) | JP2021525738A (https=) |
| KR (1) | KR102344295B1 (https=) |
| CN (1) | CN112204032A (https=) |
| AU (1) | AU2019279421A1 (https=) |
| BR (1) | BR112020023946A2 (https=) |
| CA (1) | CA3098825A1 (https=) |
| MX (1) | MX2020011955A (https=) |
| SG (1) | SG11202010985TA (https=) |
| TW (1) | TW202021969A (https=) |
| WO (1) | WO2019231270A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| IL298760A (en) | 2020-06-05 | 2023-02-01 | Kinnate Biopharma Inc | Fibroblast growth factor receptor kinase inhibitors |
| EP4067357A1 (en) * | 2021-03-30 | 2022-10-05 | JW Pharmaceutical Corporation | Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate |
| CN113929634A (zh) * | 2021-11-22 | 2022-01-14 | 山西永津集团有限公司 | 一种2,3-二溴喹喔啉的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE358395B (https=) * | 1967-09-27 | 1973-07-30 | Siegfried Ag | |
| BRPI0407926A (pt) * | 2003-03-27 | 2006-02-21 | Pfizer Prod Inc | 4-amino[1,2,4]triazol[4,3-a]quinoxalinas substituìdas |
| TW201024297A (en) * | 2008-09-10 | 2010-07-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| TW201204727A (en) * | 2010-03-10 | 2012-02-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| TW201206936A (en) * | 2010-07-19 | 2012-02-16 | Alcon Res Ltd | Methods and compositions for the treatment of allergy |
| TWI551600B (zh) * | 2011-09-30 | 2016-10-01 | Ｃ＆Ｃ新藥研究所 | 新穎雜環衍生物及其用途 |
| CA2904364A1 (en) * | 2013-03-15 | 2014-09-25 | Epigenetix, Inc. | Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors |
| JP2018537450A (ja) * | 2015-11-16 | 2018-12-20 | ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダＦｕｎｄａｃｉｏｎ Ｐａｒａ Ｌａ Ｉｎｖｅｓｔｉｇａｓｉｏｎ Ｍｅｄｉｃａ Ａｐｌｉｃａｄａ | Ｄｎａメチルトランスフェラーゼ阻害剤としての新規化合物 |
| JP7212612B2 (ja) * | 2016-07-28 | 2023-01-25 | プロメガ コーポレイション | セレンテラジン類縁体 |
-
2019
- 2019-05-30 TW TW108118749A patent/TW202021969A/zh unknown
- 2019-05-31 JP JP2020566706A patent/JP2021525738A/ja not_active Withdrawn
- 2019-05-31 US US17/057,753 patent/US20210198259A1/en not_active Abandoned
- 2019-05-31 AU AU2019279421A patent/AU2019279421A1/en not_active Abandoned
- 2019-05-31 CA CA3098825A patent/CA3098825A1/en active Pending
- 2019-05-31 MX MX2020011955A patent/MX2020011955A/es unknown
- 2019-05-31 SG SG11202010985TA patent/SG11202010985TA/en unknown
- 2019-05-31 EP EP19810281.6A patent/EP3807282A4/en not_active Withdrawn
- 2019-05-31 CN CN201980035540.4A patent/CN112204032A/zh active Pending
- 2019-05-31 BR BR112020023946-1A patent/BR112020023946A2/pt not_active Application Discontinuation
- 2019-05-31 WO PCT/KR2019/006553 patent/WO2019231270A1/en not_active Ceased
- 2019-05-31 KR KR1020190064284A patent/KR102344295B1/ko not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6574039B2 (ja) | Ｐｉ３ｋ阻害剤としてのヘテロシクリルアミン | |
| KR102329162B1 (ko) | 카이네이즈 저해제로서의 피라졸로피리미딘 유도체 | |
| ES2704024T3 (es) | Moduladores P2X7 | |
| JP2021525738A5 (https=) | ||
| AU2011267385A1 (en) | Heteroaryl imidazolone derivatives as JAK inhibitors | |
| US20200115384A1 (en) | Pde9 inhibitor and use thereof | |
| AU2015225745A1 (en) | Heterocyclic compounds | |
| RO121272B1 (ro) | Azolotriazine şi pirimidine | |
| AU2010335556A1 (en) | Imidazopyridine derivatives as JAK inhibitors | |
| KR20150135794A (ko) | 6-(5-히드록시-1h-피라졸-1-일)니코틴아미드 유도체 및 ｐｈｄ의 저해제로서의 그의 용도 | |
| US7026317B2 (en) | Pyrazolotriazines as CRF antagonists | |
| JP2017534663A (ja) | サーチュイン調節因子としての置換架橋尿素類似体 | |
| KR102344295B1 (ko) | 헤테로사이클 유도체 및 이의 용도 | |
| AU2017265383B2 (en) | Treatment of neurological disorders | |
| CA2823935A1 (en) | Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| EP3576743B1 (en) | 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors | |
| JPWO2019231270A5 (https=) | ||
| HK40026045A (en) | Pde9 inhibitor and use thereof | |
| HK1241863A1 (en) | Heterocyclylamines as pi3k inhibitors | |
| HK40011502A (en) | Heterocyclylamines as pi3k inhibitors | |
| HK40011502B (en) | Heterocyclylamines as pi3k inhibitors | |
| HK1241863B (en) | Heterocyclylamines as pi3k inhibitors | |
| HK1199644B (en) | Heterocyclylamines as pi3k inhibitors |